薬物標的タンパク質における不安定なZn部位の特定
Yu-Ming Lee1, Yi-Ting Wang, Yulander Duh
1Institute of Biomedical Sciences and §Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan.
Journal of the American Chemical Society
|September 10, 2013
まとめ
研究者らは,タンパク質に潜伏するラビル亜鉛指 (Zfs) を潜在的薬物標的として特定した. これらの特定のタンパク質構造は,亜鉛を放出する物質と反応し,展開し,新たな治療戦略を提供する.
科学分野:
- バイオケミストリー バイオケミストリー
- 構造生物学 構造生物学とは
- 薬用化学 薬用化学について
背景:
- ラビル亜鉛指 (Zfs) は,電友性物質に敏感なZn結合チオラートを持っています.
- これらの相互作用は,亜鉛 (((2+) 射出とそれに続くタンパク質の展開につながる可能性があります.
- Cys4やCys3などの特殊な構造的特徴,水素結合のないCysを持つコアが,ラビルなZfs.を特徴づける.
研究 の 目的:
- タンパク質の不安定な亜鉛指を潜在的薬物標的として識別する.
- 構造的特徴に基づいてこれらのラビルZfを特定するための戦略を検証する.
- 薬剤開発のためのラビルZfの包括的なセットを提供すること.
主な方法:
- 構造的特徴 (Cys4,Cys3His核,水素結合の欠如) に基づいて,不安定な亜鉛指を予測するためのバイオ情報分析.
- 予想される不安定なZfs.の反応性をテストするために,亜鉛発射剤を用いた実験的検証.
- Zn放出剤に曝露した際の,不活性なZfsを有するおよび無するタンパク質の比較分析.
主要な成果:
- さまざまなタンパク質における,可変性亜鉛指の包括的なセットを成功裏に特定した.
- 予測された不安定なZfsを持つタンパク質がZn放出剤と反応することを実証した.
- Zfs が存在しないまたは無効であるタンパク質は,これらの薬剤との有意な反応性を示していないことが確認されました.
結論:
- 不安定な亜鉛指は,有望な新薬標的を代表しています.
- 特定された構造的特徴は,不安定なZfs.を予測するための信頼できる方法を提供します.
- この発見は,亜鉛を放出する化合物の再設計を指し示し,特異性と治療の可能性を高めることを目的としています.
関連する概念動画
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Ligand Binding and Linkage
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...


